Skip to main content
Search form
Search
Medicines for Malaria Venture
Developing antimalarials to save lives
Research & Development
MMV-supported projects
R&D areas of work
Next-generation medicines
Products for key populations
Working with regulators
Information for scientists
Malaria online course
Global health compound design webinars
Call for proposals
TPPs & TCPs
Learning resources for scientists
Project of the year award
Computational chemistry
R&D challenges
Access
Products & projects
Product availability maps
Areas of work
Supporting introduction
Enhancing reach
Informing R&D
Gathering market intelligence
Tool Kits
Injectable Artesunate tool kit
Artesunate rectal capsules tool kit
Seasonal Malaria Chemoprevention tool kit
Access challenges
Partnering
The PDP model
Our partner network
Our donors
Current donors
Past donors
Donate to MMV
Socially responsible agreements
Our clinical centre partners
Our impact
Milestones
Real life stories
Better medicines for children
Gender equity
Global health security
Malaria and COVID-19
Tackling antimicrobial resistance
About us
What we do
An overview of our work
Our strategic focus
Our history
People & governance
Staff bios
Staff interviews
Board of Directors
MMV North America Board
Expert Scientific Advisory Committee
Access & Product Management Advisory Committee
Global Safety Board
Work with us
Jobs
RFPs/RFIs
Policies
Diversity at MMV
Funding and expenditure
FAQs
Contact us
Malaria & medicines
Definitions and symptoms
Five species
Parasite lifecycle
Malaria facts & figures
Malaria treatment
History of antimalarials
Newsroom
News & Press Releases
Audio
Media interviews
Speaking of Malaria podcast
Films
Infographics
Interviews
Image slideshows
Publications
Events
MMV Open
Malaria
Libre
About Malaria
Libre
Participate in Malaria
Libre
Malaria
Libre
data repository
MMVSola
About MMVSola
Pandemic Response Box
About the Pandemic Response Box
Request the Pandemic Response Box
Supporting information
Terms & conditions
COVID Box
About the COVID Box
Supporting information
COVID Box terms and conditions
Archived projects
Pathogen Box
Malaria Box
MMV Open Team
Contact us
Home
Newsroom
News & Press Releases
News & Press Releases
Filter
Category
All
News story
Press release
Topic
Access & product management
Donors
General
Open source
Partner
R&D
Search Terms
458 found
Japanese global health fund announces new investment in promising compounds for antimalarial drug discovery
05 Feb 2015
Independent Safety Monitoring Board assessment enables recruitment of 2-5 year olds into OZ439/PQP Phase IIb trial
20 Jan 2015
First Chair of MMV’s ESAC receives knighthood
12 Jan 2015
WHO’s much-awaited World Malaria Report reveals progress in the fight against malaria
10 Dec 2014
Three new roads leading to a common pathway
09 Dec 2014
MMV announces collaborations with Cipla and Strides
27 Nov 2014
Call for stories and ideas for GMAP2
20 Nov 2014
Child-friendly antimalarial reaches new landmark of 250 million treatments delivered
19 Nov 2014
MMV partner Prof. Luiz Carlos Dias receives Santander University Award
13 Nov 2014
300,000 vials of injectable artesunate delivered to Kenya and Nigeria
04 Nov 2014
Guilin’s SP+AQ added to WHO’s “List of Prequalified Products”
29 Oct 2014
Pyramax now registered in Cambodia
15 Oct 2014
NIH scientist Dr Martin John Rogers has passed away
09 Sep 2014
MMV organizes international malaria conference in Berlin
01 Jul 2014
MMV launches the Seasonal Malaria Chemoprevention Tool Kit
29 Apr 2014
GSK and MMV announce start of Phase III programme of tafenoquine
28 Apr 2014
MMV and Merck Serono join forces in antimalarial drug discovery
24 Feb 2014
MMV and partners call for compounds to fill the Pathogen Box
18 Feb 2014
Potential new antimalarial drug identified at the University of Dundee
06 Feb 2014
Takeda collaborates with MMV through GHIT Fund
24 Dec 2013
Breakthrough Therapy designation for potential new anti-relapse medicine for malaria
20 Dec 2013
Tafenoquine successfully completes Phase IIb clinical trials
19 Dec 2013
Rise in R&D funding could set the stage for malaria eradication
10 Dec 2013
State-of-the-art laboratory to study new antimalarials opens in Jakarta
10 Dec 2013
New antimalarial drug target identified
29 Nov 2013
Partners commit to bolstering open source research
27 Nov 2013
MMV signs MoU with Takeda and GHIT (Japan)
11 Nov 2013
MMV partner receives PLOS Accelerating Science Award
23 Oct 2013
First-ever drug compound developed on African soil, an antimalarial, to move to human trials
08 Oct 2013
Eurartesim® begins ‘real-life’ post African registration safety and effectiveness testing
03 Oct 2013
Campaign launched to help eliminate malaria deaths
23 Sep 2013
MMV’s ‘Challenge Model’ creates a buzz in Australia
16 Sep 2013
Potential new class of antimalarials now open source
10 Sep 2013
DFID pledges further support for MMV
22 Aug 2013
MMV receives funding to develop drugs to accelerate malaria eradication
22 Aug 2013
Australian first to advance malaria medicines
19 Aug 2013
African research is rising
12 Jul 2013
Japan launches bold effort to fight neglected diseases
31 May 2013
WHO approves injectable artesunate 30mg & 120mg
24 May 2013
MMV welcomes appointment of UK MP as Global Advocate for Malaria
17 May 2013
World Malaria Day 2013
25 Apr 2013
MMV and WHO launch new malaria map tool
25 Apr 2013
Winners of malaria photo contest announced
22 Apr 2013
Japan’s First PPP to Spearhead Innovation in Global Health
08 Apr 2013
Malaria in Brazil: David Reddy interviewed by Brazilian Society of Tropical Medicine
04 Apr 2013
Who will win ‘Malaria: The BIG picture’ contest: you decide!
25 Mar 2013
Quinolones: breathing new life into an old class of compounds to tackle malaria
20 Mar 2013
US policy and funding landscape for global health R&D in 2013 and beyond
15 Mar 2013
Eurartesim® (dihydroartemisinin-piperaquine) registered in first African country
07 Mar 2013
Ray Chambers appointed by UN to step-up financing for health related-MDGs
06 Mar 2013
New pack for Injectable Artesunate (InjAS) accepted by WHO Prequalification
25 Feb 2013
Salt pumps: A chink in the malaria parasite’s armour
21 Feb 2013
Malaria: The BIG Picture
15 Feb 2013
James Cochrane to receive Queen’s New Year honour
08 Jan 2013
MMV and partners handover SMS for Life in Tanzania to Government
07 Jan 2013
Malaria funding falls short by half
18 Dec 2012
MMV to advance WHO-TDR’s pioneering studies on intrarectal artesunate
14 Dec 2012
Focusing on malaria drug discovery
13 Dec 2012
UNITAID awards MMV-led consortium up to US$ 34 million
11 Dec 2012
Open access initiative reveals drug hits for deadly neglected tropical diseases
13 Nov 2012
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »